ResearcherMashhad University of Medical SciencesNo recent work listed
Abolfazl Avan
Matched on ORCID iD 0000-0002-5537-6385; OpenAlex author ID A5101889689. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2014: 2 papers · 2015: 1 paper
Papers 3
- Pharmacogenomic modeling in pancreatic cancer—letter. First author DOI 10.1158/1078-0432.ccr-14-2951↗
- Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. First author DOI 10.1038/bjc.2013.681↗
- AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. Co-author DOI 10.1371/journal.pone.0108057↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mina Maftouh · 3 shared papers, 2014–2015 · strength 0.14
- Paper Pharmacogenomic modeling in pancreatic cancer—letter. DOI 10.1158/1078-0432.ccr-14-2951↗
- Paper AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. DOI 10.1371/journal.pone.0108057↗
- Paper Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in h… DOI 10.1038/bjc.2013.681↗
- Majid Ghayour‐Mobarhan · 2 shared papers, 2014–2015 · strength 0.10
- Niccola Funel · 2 shared papers, 2014 · strength 0.08
- Ugo Boggi · 2 shared papers, 2014 · strength 0.08
- Godefridus J. Peters · 2 shared papers, 2014 · strength 0.08
- Elisa Giovannetti · 2 shared papers, 2014 · strength 0.08
- Sharareh Gholamin · 1 shared paper, 2015 · strength 0.06
- Amir Avan · 1 shared paper, 2015 · strength 0.06
- Amir Avan · 1 shared paper, 2014 · strength 0.04
- Andrea Mambrini · 1 shared paper, 2014 · strength 0.04
- Maurizio Cantore · 1 shared paper, 2014 · strength 0.04
- Tessa Y. S. Le Large · 1 shared paper, 2014 · strength 0.04
- Rocco Sciarrillo · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.